Type 2 diabetes (T2D) and heart failure (HF) are two of the most prevalent chronic conditions worldwide, both of which contribute significantly to global morbidity and mortality rates. Individuals with T2D are at a 2-5 times higher risk of developing HF. At the same time, a substantial proportion of patients with HF also suffer from diabetes, introducing complex clinical challenges that complicate the management of both conditions. This article explores the links between T2D and HF, with a particular focus on shared pathophysiological mechanisms, risk factors, and clinical implications. Through a systematic literature review of peer-reviewed studies, this research identifies and critically evaluates the common pathways that contribute to the development and progression of both conditions, such as insulin resistance, chronic inflammation, and obesity-induced lipotoxicity. Additionally, the study discusses the impact of these mechanisms on the heart. It explores the potential for integrated therapeutic strategies aimed at simultaneously managing the metabolic and cardiovascular risks associated with T2D and HF. The findings underscore the importance of a holistic approach to patient care, emphasizing the need for early intervention and targeted treatments that address the dual burden of these interrelated conditions.
Read full abstract